SIGLEC9 and breast cancer: Using novel chSiglec‐9 Jurkat/MA reporter cells, no Siglec‐9 signalling could be detected in any of the breast cancer cell lines, even though some cell lines displayed significant levels of Siglec‐9 ligands.